Capital Research Global Investors Insulet Corp Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Insulet Corp stock. As of the latest transaction made, Capital Research Global Investors holds 7,772,404 shares of PODD stock, worth $2.02 Billion. This represents 0.39% of its overall portfolio holdings.
Number of Shares
7,772,404
Previous 7,151,023
8.69%
Holding current value
$2.02 Billion
Previous $1.44 Billion
25.36%
% of portfolio
0.39%
Previous 0.33%
Shares
29 transactions
Others Institutions Holding PODD
# of Institutions
685Shares Held
62.7MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.2 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.58 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$758 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$592 Million0.4% of portfolio
-
Geode Capital Management, LLC Boston, MA1.74MShares$452 Million0.03% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...